An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Therapeutic Use
- 28 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Jun 2019.
- 25 Sep 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated